Description
Biomarker Screening: The Future of Precision Medicine and Improving Health Access
Biomarkers are biological characteristics helping increasingly in the prediction, cause, diagnosis, progression, and regression of disease, and as a consequence of therapeutic treatments or medical interventions. Scientific and medical experts will discuss the science and application of biomarker testing, including multi-cancer screening, and how biomarkers have advanced treatment for many patients and the critical need to make testing more accessible for Michiganders.
Eliot Codner, Biomarker Testing Account Executive, Genentech
Julia Feygin, PhD, Senior Medical Science Liaison, GRAIL
Diane Taglioli-Hura, Public Health Researcher, Henry Ford & Patient Advocate
